| Curcumin disrupts uterine leiomyosarcoma cells through AKT-mTOR pathway inhibition TF Wong, T Takeda, B Li, K Tsuiji, M Kitamura, A Kondo, N Yaegashi Gynecologic oncology 122 (1), 141-148, 2011 | 58 | 2011 |
| Curcumin induces cross-regulation between autophagy and apoptosis in uterine leiomyosarcoma cells B Li, T Takeda, K Tsuiji, TF Wong, M Tadakawa, A Kondo, S Nagase, ... International Journal of Gynecologic Cancer 23 (5), 2013 | 51 | 2013 |
| Association of keap1 and nrf2 genetic mutations and polymorphisms with endometrioid endometrial adenocarcinoma survival TF Wong, K Yoshinaga, Y Monma, K Ito, H Niikura, S Nagase, ... International Journal of Gynecologic Cancer 21 (8), 2011 | 48 | 2011 |
| Epigallocatechin-3-gallate potentiates curcumin’s ability to suppress uterine leiomyosarcoma cell growth and induce apoptosis A Kondo, T Takeda, B Li, K Tsuiji, M Kitamura, TF Wong, N Yaegashi International journal of clinical oncology 18, 380-388, 2013 | 31 | 2013 |
| Curcumin targets the AKT–mTOR pathway for uterine leiomyosarcoma tumor growth suppression TF Wong, T Takeda, B Li, K Tsuiji, A Kondo, M Tadakawa, S Nagase, ... International Journal of Clinical Oncology 19, 354-363, 2014 | 26 | 2014 |
| Guidelines for office gynecology in Japan: Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists 2011 edition T Takeda, TF Wong, T Adachi, K Ito, S Uehara, Y Kanaoka, M Kamada, ... Journal of Obstetrics and Gynaecology Research 38 (4), 615-631, 2012 | 23 | 2012 |
| The antidiabetic drug metformin inhibits uterine leiomyoma cell proliferation via an AMP-activated protein kinase signaling pathway B Li, T Takeda, K Tsuiji, A Kondo, M Kitamura, TF Wong, N Yaegashi Gynecological Endocrinology 29 (1), 87-90, 2013 | 22 | 2013 |
| Estrogen formulations and beauty care practices in Japanese women T Takeda, TF Wong, M Kitamura, N Yaegashi International Journal of Women's Health, 19-24, 2012 | 3 | 2012 |
| EFFICACY EVALUATION OF HYBRID CAPTURE II WITH ASC-US IN PREGNANT WOMEN: A SINGLE-INSTITUTE REVIEW OF 84 PATIENTS. A Tozawa, H Endo, TF Wong, Y Nagasawa, H Yamanaka, N Yokomichi, ... INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 28, 570-570, 2018 | | 2018 |
| FIGO STAGE IIIB AND IVA, TREATMENT AND PROGNOSIS OF THE BULKY CERVICAL CANCER S Kuji, TF Wong, H Yamanaka, Y Nagasawa, N Yokomichi, A Miura, ... INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 28, 315-315, 2018 | | 2018 |
| Multivariable analysis on treatment outcome of ovarian mucinous adenocarcinoma for the past 10 years in St. Marianna University School of Medicine Hospital. J Takeuchi, N Yokomichi, TF Wong, H Yamanaka, Y Nagasawa, A Kondo, ... INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 26, 836-836, 2016 | | 2016 |
| Keap1 and Nrf2 genetic mutations and polymorphisms: Associations with clinical outcome in endometrial cancer TF Wong, K Yoshinaga, Y Monma, K Ito, H Niikura, S Nagase, ... Cancer Research 71 (8_Supplement), 316-316, 2011 | | 2011 |
| ISO-5 Mutation Analyses of Keap1 and Nrf2 Genes in Endometrial Cancer (Group1 Oncology, International Session: Oral Presentation) TF Wong, K Yoshinaga, H Niikura, K Ito, N Yaegashi 日本産科婦人科學會雜誌 62 (2), 771, 2010 | | 2010 |
Masayuki YamamotoTohoku University, Professor在 tohoku.ac.jp 的电子邮件经过验证
Masayuki YamamotoTohoku University, Professor在 tohoku.ac.jp 的电子邮件经过验证